Skip to content

    ADD & ADHD Health Center

    Font Size
    A
    A
    A

    Experts Urge Stern ADHD Drug Warnings

    Surprise Vote Follows Preliminary Study Suggesting Risks

    FDA Reluctant

    Officials said they would be reluctant to place a black box warning on the drugs' labels based on a theoretical risk. Such warnings could deter patients and doctors from using a drug that could benefit them, said Robert Temple, MD, director of medical policy at the FDA's Center for Drug Evaluation and Research.

    "The absence of bona fide problems in your hand pushes against the box," Temple said. "We will also, frankly, worry about the possibility that overstatement can do active harm."

    Temple said the agency would wait for the advice of a pediatric advisory committee in March before reaching a decision on new warnings. That panel consists of pediatricians and psychiatrists who are more likely to look favorably on the benefits of ADHD treatment.

    Preliminary Study of Risks

    The recommendation came after FDA scientists presented a preliminary study implicating stimulant drugs with a possible increased risk of heart attacks and strokes.

    A study of approximately 676,000 patients found an elevated occurrence of heart attacks and strokes in adults taking ADHD drugs, including Adderall, Ritalin, and Concerta. Children on the drugs also showed a higher-than-expected number of strokes, though their rate of heart attacks was lower than expected.

    Strattera, another drug used to treat ADHD, is not a stimulant but was also included in the study. The expert panel did not include Strattera in their recommendation to add a warning.

    In all, the study found 49 cases of heart attacks in children and adolescents who had taken ADHD drugs. That's compared with 12 attacks expected in that age group, based on national health data.

    In adults, 732 heart attacks were observed where only 218 were expected, and 401 strokes occurred where 164 were expected.

    Researchers stressed that the findings were preliminary and, at this point, theoretical. The study did not determine whether or not patients were actually taking ADHD drugs when they died. It also did not account for existing health conditions or other drugs patients may have been taking.

    "There's smoke. Does that mean there's fire, or not?" said David Graham, MD, an FDA safety reviewer who conducted the study. "Our concern is enough to motivate us to want to nail down the uncertainty."

    Today on WebMD

    Post it notes
    Symptoms and treatments.
    Close up of eye
    What's zapping your focus?
     
    man driving car
    How to manage your impulses.
    contemplating woman
    Learn to stop procrastinating.
     
    concentration killers
    SLIDESHOW
    Woman taking a vitamin or supplement
    Article
     
    ADHD and Substance Abuse
    Article
    Reduce Side Effects ADHD Medications
    Article
     

    woman with adhd doing college homework
    Article
    smiling man
    Article
     
    ADHD in Marriage and Romantic Relationships
    Article
    Adult man lying awake in bed
    Article